<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR820.html">Part 820
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  820.198  Complaint files.
                            </h3>
                            <p class="depth1"><em>(a)</em> Each manufacturer shall maintain complaint files. Each manufacturer shall establish and maintain procedures for receiving, reviewing, and evaluating complaints by a formally designated unit. Such procedures shall ensure that:</p><p class="depth2"><em>(1)</em> All complaints are processed in a uniform and timely manner;</p><p class="depth2"><em>(2)</em> Oral complaints are documented upon receipt; and</p><p class="depth2"><em>(3)</em> Complaints are evaluated to determine whether the complaint represents an event which is required to be reported to FDA under part 803 of

this chapter, Medical Device Reporting.</p><p class="depth1"><em>(b)</em> Each manufacturer shall review and evaluate all complaints to determine whether an investigation is necessary. When no investigation is made, the manufacturer shall maintain a record that includes the reason no investigation was made and the name of the individual responsible for the decision not to investigate.</p><p class="depth1"><em>(c)</em> Any complaint involving the possible failure of a device, labeling, or packaging to meet any of its specifications shall be reviewed, evaluated, and investigated, unless such investigation has already been performed for a similar complaint and another investigation is not necessary.</p><p class="depth1"><em>(d)</em> Any complaint that represents an event which must be reported to FDA under part 803 of this chapter shall be promptly reviewed, evaluated, and investigated by a designated individual(s) and shall be maintained in a separate portion of the complaint files or otherwise clearly identified. In addition to the information required by Sec.  820.198(e), records of investigation under this paragraph shall include a determination of:</p><p class="depth2"><em>(1)</em> Whether the device failed to meet specifications;</p><p class="depth2"><em>(2)</em> Whether the device was being used for treatment or diagnosis; and</p><p class="depth2"><em>(3)</em> The relationship, if any, of the device to the reported incident or adverse event.</p><p class="depth1"><em>(e)</em> When an investigation is made under this section, a record of the investigation shall be maintained by the formally designated unit identified in paragraph (a) of this section. The record of investigation shall include:</p><p class="depth2"><em>(1)</em> The name of the device;</p><p class="depth2"><em>(2)</em> The date the complaint was received;</p><p class="depth2"><em>(3)</em> Any unique device identifier (UDI) or universal product code (UPC), and any other device identification(s) and control number(s) used;</p><p class="depth2"><em>(4)</em> The name, address, and phone number of the complainant;</p><p class="depth2"><em>(5)</em> The nature and details of the complaint;</p><p class="depth2"><em>(6)</em> The dates and results of the investigation;</p><p class="depth2"><em>(7)</em> Any corrective action taken; and</p><p class="depth2"><em>(8)</em> Any reply to the complainant.</p><p class="depth1"><em>(f)</em> When the manufacturer's formally designated complaint unit is located at a site separate from the manufacturing establishment, the investigated complaint(s) and the record(s) of investigation shall be reasonably accessible to the manufacturing establishment.</p><p class="depth1"><em>(g)</em> If a manufacturer's formally designated complaint unit is located outside of the United States, records required by this section shall be reasonably accessible in the United States at either:</p><p class="depth2"><em>(1)</em> A location in the United States where the manufacturer's records are regularly kept; or</p><p class="depth2"><em>(2)</em> The location of the initial distributor.
[61 FR 52654, Oct. 7, 1996, as amended at 69 FR 11313, Mar. 10, 2004; 71 FR 16228, Mar. 31, 2006; 78 FR 58822, Sept. 24, 2013]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
